CCH
DEAD

Serial Number

77950302

Owner

TiGenix NV

Attorney

Kimberly Gambrel

Filing Date

Mar 4, 2010

Add to watchlist:

No watchlists yet
View on USPTO

CCH Trademark

Serial Number: 77950302 • Registration: 3922019

CCH is a trademark filed by TiGenix NV on March 4, 2010. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

TiGenix NV

Haasrode Researchpark 1724
Leuven 3001 , BE

Entity Type: 99

Trademark Details

Filing Date

March 4, 2010

Registration Date

February 22, 2011

Published for Opposition

December 7, 2010

Cancellation Date

September 24, 2021

Goods & Services

[ pharmaceutical, veterinary or medicinal preparations for the expansion and implanting of human cartilage cells in vivo; cultures and nutritional substrates for the expansion and implanting of human cartilage cells in vivo; medical in vitro diagnostic tests, namely, test strips, immunological assays and immunological products, namely, enzyme based assay systems for detection of markers of disease, for use in monitoring the expansion and implanting of human cartilage cells in vivo; hormones and substances designed for stimulating cell growth, namely, cell growth media for growing cells for medical or clinical purposes; enzymes for medical purposes; antibodies for medical purposes for the expansion of human cartilage cells in vivo ]

[ pharmaceutical, veterinary or medicinal preparations for quality control of human cartilage cells in vivo; reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in monitoring the expansion and implanting of human cartilage cells in vivo for scientific purposes ]

pharmaceutical advice; dispensing of pharmaceuticals; pharmaceutical consultation; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals in the field of expansion and implanting of human cartilage cells; veterinary and medical services; implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; medical follow-up services in the field of diagnostic testing, and monitoring and reporting the expansion and implanting of human cartilage cells in vivo; medical follow-up services; medical testing, namely, carrying out of testing of expanded or implanted human cartilage cells for medical purposes; medical diagnostic testing and monitoring of the expansion and implanting of human cartilage cells in vivo

surgical apparatus and instruments for medical or veterinary use, also in the form of kits comprising medical needles, medical syringes and biopsy instruments for expansion and implanting of human cartilage cells in vivo; biopsy kits comprising medical needles and medical syringes for harvesting, expansion and implanting of human cartilage cells in vivo, and containers for use as receptacles for harvested human cartilage cells; kits comprising medical needles, medical syringes and biopsy instruments for expansion and implanting of human cartilage cells in vivo

[ pharmaceutical research services for the expansion and implanting of human cartilage cells in vivo; pharmaceutical drug development services for the expansion and implanting of human cartilage cells in vivo; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing and diagnostics for the expansion and implanting of human cartilage cells in vivo ]

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sep 24, 2021 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 22, 2020 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Mar 27, 2017 NAS8
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Mar 27, 2017 8.PR
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 25, 2017 APRE
TEAS SECTION 8 RECEIVED
Feb 16, 2017 ES8R
REGISTERED-PRINCIPAL REGISTER
Feb 22, 2011 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 7, 2010 NPUB
PUBLISHED FOR OPPOSITION
Dec 7, 2010 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 4, 2010 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 4, 2010 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 4, 2010 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 4, 2010 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 4, 2010 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 4, 2010 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Oct 14, 2010 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Sep 24, 2010 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 13, 2010 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 11, 2010 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 10, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 10, 2010 CRFA
ASSIGNED TO LIE
Sep 10, 2010 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 23, 2010 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 13, 2010 GNRN
NON-FINAL ACTION E-MAILED
Jun 13, 2010 GNRT
NON-FINAL ACTION WRITTEN
Jun 13, 2010 CNRT
ASSIGNED TO EXAMINER
Jun 7, 2010 DOCK
NOTICE OF DESIGN SEARCH CODE MAILED
Mar 10, 2010 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 9, 2010 NWOS
NEW APPLICATION ENTERED
Mar 8, 2010 NWAP